GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Change In Payables And Accrued Expense

Q2M Biotech AG (HAM:QBI) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Change In Payables And Accrued Expense?

Q2M Biotech AG's Change In Payables And Accrued Expense for the quarter that ended in . 20 was €0.00 Mil. It means Q2M Biotech AG's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Q2M Biotech AG's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was €0.00 Mil. It means Q2M Biotech AG's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Q2M Biotech AG Change In Payables And Accrued Expense Historical Data

The historical data trend for Q2M Biotech AG's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Change In Payables And Accrued Expense Chart

Q2M Biotech AG Annual Data
Trend
Change In Payables And Accrued Expense

Q2M Biotech AG Quarterly Data
Change In Payables And Accrued Expense

Q2M Biotech AG Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q2M Biotech AG Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines